We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patients Advocate Seeks PTO Review of Wyeth’s Tygacil Patent
Patients Advocate Seeks PTO Review of Wyeth’s Tygacil Patent
A patient advocacy group is using a recently created review pathway through the U.S. Patent and Trademark Office to challenge the patent on Wyeth’s antibiotic Tygacil outside a Hatch-Waxman ANDA.